Completed
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
NCT02036853
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +7 more
- Locations
-
- Cook Childrens Medical Center Fort Worth, Texas, United States